Background. Epinephrine has been shown to impair pulmonary excretion of CO2 during resuscitation. This phenomenon was investigated in a rodent model of cardiac arrest and conventional resuscitation.
Methods and Results. The effects of racemic epinephrine were compared with the selective a1-agonist methoxamine and with saline placebo during cardiac resuscitation in 15 Conclusions. Epinephrine induced ventilation/perfusion during cardiopulmonary resuscitation as a result of redistribution of pulmonary blood flow. (Circulation 1991; 84:2101 -2107 Eipinephrine has been the preferred adrenergic amine for the management of human cardiac arrest for almost 30 years.t-3 The rationale for its use is supported by animal studies4-6 and anecdotal case reports on patients.78 There is persuasive evidence that restoration of spontaneous circulation is a result of its a-adrenergic effect, by which coronary perfusion is augmented. Redding and Pearson9 demonstrated that selective a,-adrenergic agents such as phenylephrine and methoxamine were as effective as epinephrine for restoring spontaneous circulation after electrically induced ventricular fibrillation (VF) in dogs. To the contrary, isoprotere-nol, which is the prototype of P-agonists, decreased resuscitability.
However, several adverse effects of epinephrine have more recently been identified in the setting of cardiac resuscitation. These include increases in myocardial oxygen consumption10-12 and increased ventricular dysrhythmicity due to reentrant and ectopic ventricular tachycardia. [13] [14] [15] This becomes an issue of even greater moment when "mega" doses of epinephrine are administered after conventional doses fail to increase arterial resistance and therefore coronary perfusion pressure (CPP).5s16 -19 See p 2199
Our group recently described a rat model for study of cardiac resuscitation.20 In exercising this model, we coincidentally observed that epinephrine administered during precordial compression decreased the end-tidal carbon dioxide (PETCO2) excretion, an observation previously made by Paradis et at2' in patients. We further observed that there was a simultaneous decrease in Pao2 and increase in Paco2.22 Since epinephrine has been demonstrated to alter ventilation/perfusion (VA/Q) relations,23 we suspected that this was the mechanism operative in our rat model. We therefore undertook a controlled study in which we compared the effects of epinephrine with those of a more selective a-agonist, methoxamine, in the setting of cardiac resuscitation.
Methods

Preparation
The experiments were performed in a previously described rat model of cardiac arrest and cardiac resuscitation. 20 
Experimental Procedure
The tracheal tube was connected to a volumecontrolled ventilator as previously described.20 Ventilation was initially established at a tidal volume of 0.65 ml/100 g animal wt and a frequency of 100 breaths/min. The tidal volume was subsequently adjusted to compensate for the volume of gas sampled by the CO2 analyzer so as to maintain PETCO2 between 30 and 35 mm Hg. The inspired 02 fraction (Fio2) was 0.7. A progressive increase in 60-Hz current to a maximum of 8 mA was then delivered to the RV endocardium, and current flow was continued for 3 minutes. Four minutes after onset of VF, precordial compression was initiated and maintained for 5 minutes with a pneumatically driven mechanical chest compressor as previously described.20 Compression was maintained at a rate of 200 min`with equal compression-relaxation duration (i.e., 50% duty cycle). Compression depth was equivalent to 30% of the anteroposterior diameter of the chest and was adjusted to maintain CPP at 30-35 mm Hg. Compression and ventilation were synchronized so as to maintain two compressions for each ventilation.
After 2 minutes of precordial compression (i.e., 6 minutes of VF), 0.2 ml of either epinephrine (30 gg/kg) or methoxamine (750 ug/kg) or 0.2 ml of normal saline was bolus injected into the right atrium. After 5 minutes of precordial compression (i.e., 9 minutes of VF), a 20-J DC countershock was delivered between the anterior chest and the back. If VF was not reversed within 5 seconds, a second 20-J DC countershock was delivered. In unsuccessfully resuscitated rats, precordial compression was then resumed for another 30 seconds before delivery of a second sequence of countershocks. Resuscitated rats were monitored for an additional 30 minutes, after which they were killed by intravascular injection of 2 ml of saturated KCI solution. Autopsy was routinely performed to document position of catheters and identify adverse effects of the interventions on thoracic and abdominal organs.
Measurements
For blood transfusions, arterial blood (2 ml) from a donor rat of the same colony was injected into the inferior vena cava 30 seconds before blood sampling. One-milliliter aliquots of blood were then withdrawn from both the aorta and the right atrium. Measurement of Pco2, Po2, 02 saturation (So2), HCO3-, hemoglobin, and 02 content on these samples was by techniques previously described.24 At 6 and 8 minutes of VF and at 5 and 30 minutes after resuscitation, all measurements were repeated. Aortic and right atrial pressures were continuously recorded on a six-channel recorder (model 2600, Gould Inc., Rolling Meadows, Ill.) together with the ECG and PETCO2. The CPP was calculated as the difference between compression-induced diastolic aortic and time-coincident right atrial pressures. Qs/Qt= (Cco2-Cao2)l(Cco2-Cvo2) x 100
(1) In earlier studies, we observed no differences in the Cvo2 (or PNco2) between right atrial blood sampled at a site immediately proximal to the RV and blood sampled from the pulmonary artery. Accordingly, measurements on blood from the right atrium were used for calculation of Cvo2.
The mean alveolar oxygen tension was calculated from the alveolar gas equation:
The R was assumed to be 1 as it was in an earlier study. 23 The pulmonary capillary oxygen content was assumed to be equivalent to blood equilibrated at the existing Pao2.
Statistical Analysis
The pressure, flow, and gas concentrations for epinephrine, methoxamine, and control were analyzed by analysis of variance (ANOVA), Scheff6 
Results
The control measurements did not differ significantly among the three groups.
After intra-atrial injection of epinephrine, CPP increased from 33±3 to 52±4 mm Hg (p<0.001) within 5 seconds. Comparable increases in CPP were observed with methoxamine (34+3 to 48±3 mm Hg, p<0.001). These pressure levels were maintained within ±2 mm Hg during the 5-minute interval of precordial compression. There was no increase in CPP after intra-atrial injection of saline placebo. After epinephrine, PETCO2 was strikingly decreased, from 10±2 to 5±2 mmHg (p<0.001) ( Table 1) . However, no such decreases in PETCO2 followed injection of either methoxamine or saline placebo (Figure 1 ). The decrease in PETCO2 that followed injection of epinephrine was associated with an increase in the estimate of pulmonary arteriovenous shunt from 12+2% to 27±3% (p<0.001). No such effects were observed after administration of methoxamine (12±3% versus 14+2%) or saline placebo (13±3% versus 13±2%) (Figure 2 ). There was a corresponding decrease in Pao2 from 130±+9 to 74±6 mm Hg (p<0.001) and prominent increases in Paco2 from 26+4 to 40+5 mm Hg (p<0.001) after administration of epinephrine. However, there were no significant changes in arterial PvO2 or Pvco2 ( ever, epinephrine decreased PETCO2 without a corresponding change in Paco2. Accordingly, epinephrine increased the alveolar-arterial Pco2 gradient and therefore the alveolar dead space. Since tidal volume and respiratory rate were constant, these changes strongly suggest that epinephrine altered the distribution of pulmonary blood flow such that a large fraction of the lung became underperfused.37-39 A corresponding increase in flow through the remaining lung favored not only venous admixture but also the narrowing of the venoarterial Pco2 gradient and therefore the increase in Paco2. Since the alterations in gas exchange were not observed after administration of the selective a,- Accordingly, our studies suggest that epinephrine alters the distribution of blood flow within the pulmonary circuit. The stimulation of a-adrenoreceptors, especially of well-ventilated areas, would shunt blood away from these well-ventilated areas (deadspace effect) and preferentially distribute blood flow toward poorly ventilated regions in which the /3-adrenoreceptor action had released hypoxic vasoconstriction (venous admixture effect). The already altered pulmonary gas exchange during cardiac arrest and resuscitation would set the condition under which these unfavorable effects of epinephrine are manifested. 49 There is little controversy that a-adrenergic agonists facilitate cardiopulmonary resuscitation after asphyxial cardiac arrest in dogs.50 Moreover, a-receptor blockade with phenoxybenzamine before injection of epinephrine decreased resuscitability. This contrasted with high levels of effectiveness when epinephrine was administered after /3-receptor blockade with propranolol. Equivalent effectiveness was demonstrated after administration of a relatively pure a-adrenergic agonist, phenylephrine. Otto et a151 induced cardiac arrest by VF in dogs and confirmed that it was the a-agonists that accounted for the effectiveness of epinephrine. Conversely, when a-receptors were blocked or after administration of f3-adrenergic isoproterenol, attempts at resuscitation of dogs after electrically induced VF failed.
The greater ease of electrical defibrillation after either saline or methoxamine in contrast to epinephrine would also support the notion that the ,B-adrenergic effects of epinephrine may adversely affect resuscitability. Whether these effects are caused primarily by ventricular dysrhythmias independently of or together with pulmonary venous admixture is not fully clarified.'3,14,52-54 However, /3-adrenergic stimulation of the fibrillating heart increases myocardial oxygen requirement such that for any given level of myocardial blood flow generated by precordial compression, the oxygen deficit is likely to be increased. [10] [11] [12] The value of PETCO2 as a reliable hemodynamic monitor during cardiac resuscitability is also at issue.55-58 These experiments also confirm that PETC02 may lose its predictive value after the administration of epinephrine.
